ALSUntangled #63: ketogenic diets

References

• ALSUntangled. Available at: https://www.alsuntangled.com/future-reviews/. Accessed July 23, 2021.
   Google Scholar
• Wikipedia. Available at: https://en.wikipedia.org/wiki/Ketogenic_diet. Accessed August 6, 2021.
   Google Scholar
• Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2020;2020:CD001903.
   Google Scholar
• Gano L, Patel M, Jong R. Ketogenic diets, mitochondria, and neurological diseases. J Lipid Res. 2014;55:2211–28.
   PubMed Web of Science ®Google Scholar
• Paganoni S, Wills A. High-fat and ketogenic diets in amyotrophic lateral sclerosis. J Child Neurol. 2013;28:989–92.
   PubMed Web of Science ®Google Scholar
• Dr. David Perlmutter. Available at: https://www.drperlmutter.com/use-ketogenic-diet-treating-als/. Accessed August 6, 2021.
   Google Scholar
• Veyrat-Durebex C, Reynier P, Procaccio V, Hergesheimer R, Corcia P, Andress C, et al. How can a ketogenic diet improve motor function? Front Mol Neurosci. 2018;11:15.
   PubMed Web of Science ®Google Scholar
• Vandoorne T, De Bock K, Van Den Bosch L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol. 2018;135:489–509.
   PubMed Web of Science ®Google Scholar
• Bough K, Wetherington J, Hassel B, Pare J, Gawryluk J, Green J, et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol. 2006;60:223–5.
   PubMed Web of Science ®Google Scholar
• Nylen K, Perez Velazquez J, Sayed V, Gibson K, Burnham W, Snead O. The effects of a ketogenic diet on ATP concentrations and the number of hippocampal mitochondria in Aldh5a1(-/-) mice. Biochim Biophys Acta. 2009;1790:208–12.
   PubMed Web of Science ®Google Scholar
• Masino S, Gockel S, Wasser C, Pomeroy L, Wagener J, Gawryluk J, et al. The relationship among ATP, adenosine, and a ketogenic diet. Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience; 2007.
   Google Scholar
• Zhao Z, Lange D, Voustianiouk A, MacGrogan D, Ho L, Suh J, et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006;7:29.
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Thompson JLP, Levy G, Buchsbaum R, Shefner J, Krivickas LS, et al. Phase II trial of coQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol. 2009;66:235–44.
   PubMed Web of Science ®Google Scholar
• Cudkowicz M, van den Berg L, Shefner J, Mitsumoto H, Mora J, Ludolph A, et al. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomized, double-blind, phase 3 trial. Lancet Neurol. 2013;12:1059–67.
   PubMed Web of Science ®Google Scholar
• Rosenblum L, Trotti D. EAAT2 and the molecular signature of amyotrophic lateral sclerosis. Adv Neurobiol. 2017;16:117–36.
   PubMedGoogle Scholar
• Blasco H, Mavel S, Corcia P, Gordon P. The glutamate hypothesis in ALS: pathophysiology and drug development. Curr Med Chem. 2014;21:3551–75.
   PubMed Web of Science ®Google Scholar
• Bellingham M. A review of the neuronic mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the past decade? CNS Neurosci Ther.2011;17:4–31.
   PubMed Web of Science ®Google Scholar
• LeVerche V, Ikiz B, Jacquier A, Przedborski S, Re D. Glutamate pathway implication in amyotrophic lateral sclerosis: what is the signal in the noise? J Recept Ligand Channel Res. 2011;4:1–22.
   Google Scholar
• Juge N, Gray JA, Omote T, Miyaji T, Inoue C, Hara H, et al. Metabolic control of vesicular glutamate transport and release. Neuron 2010;68:99–112.
   PubMed Web of Science ®Google Scholar
• Melo T, Nehlig A, Sonnewald U. Neuronal-glial interactions in rats fed a ketogenic diet. Neurochem Int. 2006;48:498–507.
   PubMed Web of Science ®Google Scholar
• Kallstig E, McCabe B, Schneider B. The links between ALS and NF-kB. IJMS. 2021;22:3875.
   Google Scholar
• Bright F, Chan G, van Hummel A, Ittner LM, Ke YD. TDP-43 and inflammation: implications for amyotrophic lateral sclerosis and frontotemporal dementia. IJMS. 2021;22:7781.
   Google Scholar
• Koh S, Dupuis N, Auvin S. Ketogenic diet and neuroinflammation. Epilepsy Res. 2020;167:106454.
   PubMed Web of Science ®Google Scholar
• Obrador E, Salvador-Palmer R, López-Blanch R, Jihad-Jebbar A, Vallés SL, Estrela JM. The link between oxidative stress, redox status, bioenergetics, and mitochondria in the pathophysiology of ALS. IJMS. 2021;22:6352.
   Google Scholar
• Writing Group; Edaravone ALS 19 Study Group. Safety and efficacy of edaravone in well-defined patients with amyotrophic lateral sclerosis: a double-blind, placebo-controlled clinical trial. Lancet Neurol. 2017;16:505–12.
   PubMed Web of Science ®Google Scholar
• Orrell RW, Lane RJM, Ross M. Antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2005;1:CD002829.
   Google Scholar
• Milder J, Patel M. Modulation of oxidative stress and mitochondrial function by the ketogenic diet. Epilepsy Res. 2012;100:295–303.
   PubMed Web of Science ®Google Scholar
• Kephart W, Mumford P, Mao X, Romero M, Hyatt H, Zhang Y, et al. The 1-week and 8-moth effects of a ketogenic diet or ketone salt supplementation on multi-organ markers of oxidative stress and mitochondrial function in rats. Nutrients. 2017;9:1019.
   PubMed Web of Science ®Google Scholar
• The ALSUntangled Group. ALSUntangled: introducing the table of evidence. Amyotroph Lateral Scler Frontotemporal Degen. 2015;16:142–5.
   PubMed Web of Science ®Google Scholar
• Zhao W, Varghese M, Vempati P, Dzhun A, Cheng A, Wang J, et al. Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS One. 2012;7:e49191.
   PubMed Web of Science ®Google Scholar
• Benatar M. Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis. 2007;26:1–13.
   PubMed Web of Science ®Google Scholar
• PatientsLikeMe. Available at: https://www.patientslikeme.com/treatment/ketogenic-diet. Accessed August 18, 2021.
   Google Scholar
• Personal communication with Gleb Levitsky August 23, 2021.
   Google Scholar
• Clawson R, Kimball R, Kossoff E, Chaudry V. Use of a ketogenic diet in a patient with amyotrophic lateral sclerosis. Presented at 2015 Northeast ALS Consortium Meeting in Clearwater Florida. 2015.
   Google Scholar
• Wills A, Hubbard J, Macklin E, Glass J, Tandan R, Simpson E, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383:2065–72.
   PubMed Web of Science ®Google Scholar
• Kang H, Chung D, Kim D, Kim H. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia. 2004;45:1116–23.
   PubMed Web of Science ®Google Scholar
• Wlodek D. Role of Ketogenic diets in neurodegenerative diseases. Nutrients. 2019;11:169.
   PubMed Web of Science ®Google Scholar
• Phillips M, Murtagh D, Gilbertson L, Asztely F, Lynch C. Low-fat versus ketogenic diet in Parkinson's disease: a pilot randomized controlled trial. Mov Disord. 2018;33:1306–14.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick CF, Bolick JP, Kris-Etherton PM, Sikand G, Aspry KE, Soffer DE, et al. Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: a scientific statement from the national lipid association nutrition and lifestyle task force. J Clin Lipidol. 2019;13:689–711.
   PubMed Web of Science ®Google Scholar
• Ballaban-Gil K, Callahan C, O'Dell C, Pappo M, Moshé S, Shinnar S. Complications of the ketogenic diet. Epilepsia. 1998;39:744–8.
   PubMed Web of Science ®Google Scholar
• Bueno N, de Melo I, de Oliveira S, Ataide T. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomized controlled trials. Br J Nutr. 2013;110:1178–87.
   PubMed Web of Science ®Google Scholar
• Diabetes UK. Available at: https://www.diabetes.co.uk/keto/side-effects-of-ketogenic-diet.html. Accessed August 25, 2021.
   Google Scholar
• Janse van Mantgem MR, van Eijk RPA, van der Burgh HK, Tan HHG, Westeneng H-J, van Es MA, et al. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2020;91:867–75.
   PubMed Web of Science ®Google Scholar
• Bank I, Shemie S, Rosenblatt B, Bernard C, Mackie A. Sudden cardiac death in association with the ketogenic diet. Pediatr Neurol. 2008;39:429–31.
   PubMed Web of Science ®Google Scholar
• Bioketo. Available at: https://bioketo.com/cost-of-the-keto-diet/. Accessed August 21, 2021.
   Google Scholar
• Epilepsy Foundation. Available at: https://www.epilepsy.com/sites/core/files/atoms/files/517TSE_DietaryTherapies_Rev09-2018_FINAL.pdf. Accessed August 25, 2021.
   Google Scholar
• Roehl K, Sewak S. Practice paper of the academy of nutrition and dietetics: classic and modified ketogenic diets for treatment of epilepsy. J Acad Nutr Diet. 2017;117:1279–92.
   PubMed Web of Science ®Google Scholar
• Freeman J, Freeman J, Kelly M. The ketogenic diet: a treatment for epilepsy. Third Edition, NY, Demos Publishing, 2000.
   Google Scholar
• Nutrition Care Manual. Available at: https://www.nutritioncaremanual.org/client_ed.cfm?ncm_client_ed_id=75. Accessed August 31, 2021.
   Google Scholar